The effect of ursodeoxycholic acid on the florid duct lesion of primary biliary cirrhosis

The frequency with which florid duct lesions are seen in needle‐biopsy specimens of the liver was assessed in patients with primary biliary cirrhosis (PBC) enrolled in a 2‐year randomized, double‐blind, placebo‐controlled trial of ursodeoxycholic acid (UDCA) versus placebo. Paired biopsy specimens obtained at entry and after 2 years on medication were reviewed blindly and mostly simultaneously by a panel of 5 hepatopathologists who, earlier, had characterized the florid duct lesion, which has been well described in the pathology literature. Florid duct lesions at entry were identified in approximately 36%. Patients with earlier disease showed florid duct lesions much more frequently than those with more advanced disease. The prevalence of florid duct lesions in 60 patients receiving placebo medication fell from 38.3% to 21.7%, P = .025, over the period of 2 years. The prevalence of florid duct lesions also decreased in the 55 patients receiving UDCA, from 32.7% to 18.2%, P = .046. The prevalences of these lesions in the placebo and UDCA patients at entry and at 2 years were not significantly different from each other. The findings suggest that UDCA does not prevent ongoing bile duct destruction in patients with PBC. Instead, they support the impression that UDCA exerts its beneficial effects by protecting against the consequences of bile duct destruction.

[1]  D. Groggel.  Practical Nonparametric Statistics , 1972, Technometrics.

[2]  K. Lindor,et al.  Primary biliary cirrhosis , 1998, Springer Netherlands.

[3]  E. Dickson,et al.  Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. , 1997, Gastroenterology.

[4]  B. Combes,et al.  Ursodeoxycholic Acid in Primary Biliary Cirrhosis , 1997, Seminars in liver disease.

[5]  T. Therneau,et al.  Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. , 1996, Gastroenterology.

[6]  U. Steinbrecher,et al.  Is the Mayo model for predicting survival useful after the introduction of ursodeoxycholic acid treatment for primary biliary cirrhosis? , 1996, Hepatology.

[7]  A. West,et al.  A randomized, double‐blind, placebo‐controlled trial of ursodeoxycholic acid in primary biliary cirrhosis , 1993, Hepatology.

[8]  B. Balkau,et al.  Ursodiol for the long-term treatment of primary biliary cirrhosis. The UDCA-PBC Study Group. , 1994, The New England journal of medicine.

[9]  U. Steinbrecher,et al.  The canadian multicenter double‐blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis , 1994, Hepatology.

[10]  E. Dickson,et al.  Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. , 1994, Gastroenterology.

[11]  D. Heuman,et al.  Hepatoprotective properties of ursodeoxycholic acid. , 1993, Gastroenterology.

[12]  L. Theilmann,et al.  [Hepatic expression of Class-I and Class-II major histocompatibility complex molecules in primary biliary cirrhosis: effect of ursodeoxycholic acid]. , 1991, Zeitschrift fur Gastroenterologie.

[13]  B. Balkau,et al.  A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. , 1991, The New England journal of medicine.

[14]  P. Gane,et al.  Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis: Effect of ursodeoxycholic acid , 1990, Hepatology.

[15]  F. BordaCelaya,et al.  [Primary biliary cirrhosis]. , 1989, Anales de medicina interna.

[16]  J. Ludwig.  New Concepts in Biliary Cirrhosis , 1987, Seminars in liver disease.

[17]  Peter J. Scheuer,et al.  Three‐dimensional reconstruction of biliary pathways in primary biliary cirrhosis: A computer‐assisted study , 1987, The Journal of pathology.

[18]  Y. Chrétien,et al.  IS URSODEOXYCHOLIC ACID AN EFFECTIVE TREATMENT FOR PRIMARY BILIARY CIRRHOSIS? , 1987, The Lancet.

[19]  J. Neuberger,et al.  Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients. , 1985, Gastroenterology.

[20]  R. Allan Reese,et al.  Practical Nonparametric Statistics , 1983 .

[21]  Y. Nakanuma,et al.  Histometric and serial section observations of the intrahepatic bile ducts in primary biliary cirrhosis. , 1979, Gastroenterology.

[22]  H. Popper,et al.  PRIMARY BILIARY CIRRHOSIS. CHRONIC NON-SUPPURATIVE DESTRUCTIVE CHOLANGITIS. , 1965, The American journal of pathology.